Clinical Trials in Detroit

Showing 17161-17180 of 19,719 trials

A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies

NCT00871559

The purpose of this study is to assess the safety and tolerability of REGN421 (SAR153192) in patients with advanced solid malignancies.

Advanced Solid Malignancies

Regeneron Pharmaceuticals83 participantsStarted Jun 2009

Aurora, Colorado, United States • Indianapolis, Indiana, United States • Boston, Massachusetts, United States +5 more locations

COMPLETEDPhase 3< 1 mile

Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis

NCT00268957

Approximately 207 patients with chronic kidney disease (CKD) on hemodialysis will be entered into this study at approximately 26 centers in the United States. This study aims to evaluate the safety and efficacy of sevelamer carbonate powder dosed once-a-day (QD) with the largest meal compared to sevelamer hydrochloride tablets dosed three-times-per-day (TID) with meals. The total length of participation is approximately 24 weeks.

Kidney DiseasesChronic Renal InsufficiencyEnd-Stage Renal Disease

Genzyme, a Sanofi Company217 participantsStarted Jan 2006

Birmingham, Alabama, United States • Gadsden, Alabama, United States • Mission Hills, California, United States +26 more locations

A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies

Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis

Find Trials by Condition in Detroit

A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer

JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors

DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension

Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone

Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension

Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy

A Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With Asthma

Cross-Over Study of Sevelamer Hydrochloride and Sevelamer Carbonate

Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With Bronchiectasis

Long-term Effects of Highly Active Anti-Retroviral Therapy on HIV-Infected Children

Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers

Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS CLIA

Study Evaluating Vabicaserin in Subjects With Schizophrenia

A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA)

Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy

Safety Study of GC1008 in Patients With Focal Segmental Glomerulosclerosis (FSGS) of Single Doses of GC1008 in Patients With Treatment Resistant Idiopathic FSGS